UB Paderborn / Katalog / Suche / in CDI

Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)

Stroke (1970), 2017-02, Vol.48 (2), p.379-387

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial

JACC. Cardiovascular interventions, 2016-11, Vol.9 (22), p.2343-2352

2016

Link zum Volltext

Verfügbarkeit prüfen

Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percutaneous coronary intervention

Coronary artery disease, 2023-01, Vol.34 (1), p.24

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial

Circulation (New York, N.Y.), 2014-09, Vol.130 (14), p.1146-1157

2014

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty

JACC. Cardiovascular interventions, 2016-11, Vol.9 (22), p.2343-2352

2016

Link zum Volltext

Verfügbarkeit prüfen

Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at Standard Surgical Risk: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)

Stroke (1970), 2012-09, Vol.43 (9), p.2408-2416

2012

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective

Heart (British Cardiac Society), 2015-12, Vol.101 (24), p.1980-1988

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF–TIMI 48 trial

The American heart journal, 2015-12, Vol.170 (6), p.1140-1150

2015

Link zum Volltext

Verfügbarkeit prüfen

Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

JACC. Cardiovascular interventions, 2017-04, Vol.10 (8), p.774-782

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost–Effectiveness of Everolimus - Versus Paclitaxel -Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization (from the SPIRIT-IV Trial)

The American journal of cardiology, 2012-09, Vol.110 (6), p.765-770

2012

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese Perspective

Value in health regional issues, 2017-05, Vol.12, p.74-83

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B)

Circulation (New York, N.Y.), 2012-03, Vol.125 (9), p.1102-1109

2012

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial

Circulation (New York, N.Y.), 2013-02, Vol.127 (7), p.820-831

2013

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial

Circulation. Cardiovascular interventions, 2022-07, Vol.15 (7), p.e011981-e011981

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial

Circulation Cardiovascular quality and outcomes, 2019-10, Vol.12 (10), p.e005659-e005659

2019

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 Trial

Circulation Cardiovascular quality and outcomes, 2020-11, Vol.13 (11), p.e006511-e006511

2020

Link zum Volltext

Verfügbarkeit prüfen

Envisioning the Evolution of Learning Healthcare Systems to a Learning Healthcare Community

Circulation Cardiovascular quality and outcomes, 2022-11, Vol.15 (11), p.e009439-e009439

2022

Link zum Volltext

Verfügbarkeit prüfen

Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial

Journal of medical economics, 2021-01, Vol.24 (1), p.570-580

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis vs. Standard Anticoagulation in Patients with Proximal Deep-Vein Thrombosis: Results from the ATTRACT Trial

Circulation Cardiovascular quality and outcomes, 2019-10, Vol.12 (10), p.e005659-e005659

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 13035: Impact of Ezetimibe on Hospitalization-Related Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A13035-A13035

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Circulation Cardiovascular quality and outcomes, 2017-05, Vol.10 (5)

2017

Link zum Volltext

Verfügbarkeit prüfen

Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III Trial

JACC. Cardiovascular interventions, 2017-04, Vol.10 (8), p.774-782

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Percutaneous Coronary Intervention with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multivessel Coronary Artery Disease: Results from the FREEDOM Trial

Circulation (New York, N.Y.), 2012-12, Vol.127 (7), p.820-831

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract P20: One-Year Hospitalization Costs Associated with Carotid Stenting Versus Endarterectomy: Results from the CREST Trial

Circulation Cardiovascular quality and outcomes, 2011-11, Vol.4 (suppl_2)

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)

Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial

Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percutaneous coronary intervention

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial

Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty

Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at Standard Surgical Risk: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective

Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF–TIMI 48 trial

Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Cost–Effectiveness of Everolimus - Versus Paclitaxel -Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization (from the SPIRIT-IV Trial)

Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese Perspective

Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B)

Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial

Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial

Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial

Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 Trial

Envisioning the Evolution of Learning Healthcare Systems to a Learning Healthcare Community

Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial

Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis vs. Standard Anticoagulation in Patients with Proximal Deep-Vein Thrombosis: Results from the ATTRACT Trial

Abstract 13035: Impact of Ezetimibe on Hospitalization-Related Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial

Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke

Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III Trial

Cost-Effectiveness of Percutaneous Coronary Intervention with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multivessel Coronary Artery Disease: Results from the FREEDOM Trial

Abstract P20: One-Year Hospitalization Costs Associated with Carotid Stenting Versus Endarterectomy: Results from the CREST Trial

Aktive Filter

Suchergebnisse filtern